This study demonstrated ML-driven design of synthetic proteins with improved function and stability. It validated the predictive power of Evozyne’s early modeling frameworks.
Why These Studies Matter
- They provide third-party confirmation of Evozyne’s core technical claims.
- They validate EvoGen as a foundation for immunology-focused therapeutic design.
- They demonstrate performance leaps only achievable through generative AI.